Drug Discovery Platform
The Future of Drug Discovery
Automated Design-Make-Test-Analyse cycle
Retrosynthesis AI
Spaya
Orchestration AI
Ilaka
Generative AI
Makya
Synthesis
Iktos Robotics
Biological testing
Iktos Robotics
Purification & analysis
Iktos Robotics
Benefits
Transforming Drug Discovery with AI and Robotics
Our fully digitized, AI-drive process enables fast progression towards optimal candidates, collecting high quality data at unprecedented speed
Increase Efficiency
Enable six times more parallel projects with the same number of chemists.
Speed Up Drug Discovery
Reduce the timeline to under 24 months.
Our Workflow
Step-by-Step Molecular Journey
Generative AI
The Autonomous Lab transforms drug discovery through a systematic molecular journey. It begins with Makya, our generative AI, which generates optimal molecules in silico.
Retrosynthesis AI
These molecules are then processed by Spaya, our retrosynthesis AI, to identify synthesis routes compatible with our robots.
Orchestration AI
Ilaka, our orchestration AI, takes over to manage the entire workflow, from ordering raw materials to overseeing synthesis campaigns and directing robots to perform the chemistry.
Robot Driven Chemistry
Our Chemspeed platform allow to run 100 reactions per day in parallel across more than 55 different named reactions.
Robot Driven Biology
High-throughput phenotypic assays obtain massive and robust data by observing several thousand of cellular events. Our patented Microtubule Bench technology (MT bench®) industrializes cell testing, a powerful technology to assess drug efficacy directly from inside the cell.
AI-driven design tightly integrated with automation
Ilaka: AI-Driven Orchestrator
Powered by our AI-driven tools Makya and Spaya
Makya designs synthetically accessible compounds, tailored for robotic synthesis.
Spaya API produces routes compatible with robotics synthesis.
Maximal synthetic output from a single robot
Ilaka applies a Cluster synthesis strategy: prioritizes routes based on inventory and reaction conditions. It creates chemically-diverse reaction clusters to maximize robot utilization.
Optimal control for chemists
The chemist reviews and validates Ilaka's planned workload with visibility over real-time robotics capacity and inventory management.
Watch the video of our robots at work
Partnering for Success
Strategic Drug Discovery Collaborations
At Iktos, we collaborate with pharmaceutical and biotech companies to drive innovation in drug discovery. Our Drug Discovery collaborations leverage our AI and robotics platforms to accelerate the development of new drug candidates.
Enhance your drug discovery projects with our advanced technologies and expert support.
Iktos' platform is supported by European Innovation Council
We are proud to have been awarded a prestigious EIC Accelerator grant to advance our AI-driven, automated drug discovery platform. This recognition underscores our pioneering work, integrating generative AI, robotics, and high-precision biological screening to accelerate the development of novel therapeutics.
